BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma S, Hopkins CR. Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases. J Med Chem 2019;62:7589-602. [PMID: 30943030 DOI: 10.1021/acs.jmedchem.8b01954] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Müller M, Niemeyer K, Urban N, Ojha NK, Zufall F, Leinders‐zufall T, Schaefer M, Thorn‐seshold O. BTDAzo: A Photoswitchable TRPC5 Channel Activator**. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202201565] [Reference Citation Analysis]
2 Amores-Bonet L, Kleene R, Theis T, Schachner M. Interactions between the Polysialylated Neural Cell Adhesion Molecule and the Transient Receptor Potential Canonical Channels 1, 4, and 5 Induce Entry of Ca2+ into Neurons. Int J Mol Sci 2022;23:10027. [PMID: 36077460 DOI: 10.3390/ijms231710027] [Reference Citation Analysis]
3 Yu Y, Jiang H, Liang Q, Qiu L, Huang T, Hu H, Bolshakov VY, Perlmutter JS, Tu Z. Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain. Mol Imaging Biol 2022. [PMID: 35951211 DOI: 10.1007/s11307-022-01760-y] [Reference Citation Analysis]
4 Strickland RG, Garner MA, Gross AK, Girkin CA. Remodeling of the Lamina Cribrosa: Mechanisms and Potential Therapeutic Approaches for Glaucoma. IJMS 2022;23:8068. [DOI: 10.3390/ijms23158068] [Reference Citation Analysis]
5 Yang Y, Wei M, Chen L. Structural identification of riluzole-binding site on human TRPC5. Cell Discov 2022;8:67. [PMID: 35821012 DOI: 10.1038/s41421-022-00410-5] [Reference Citation Analysis]
6 Zhang Z, Chen L, Tian H, Liu M, Jiang S, Shen J, Wang K, Cao Z. Discovery of pyridazinone analogs as potent transient receptor potential canonical channel 5 inhibitors. Bioorg Med Chem Lett 2022;:128612. [PMID: 35143983 DOI: 10.1016/j.bmcl.2022.128612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Belen’kii LI, Gazieva GA, Evdokimenkova YB, Soboleva NO. The literature of heterocyclic chemistry, Part XIX, 2019. Advances in Heterocyclic Chemistry 2022. [DOI: 10.1016/bs.aihch.2021.09.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Zeng W, Ji Y, Zhang H, Chen L, Du L, Guo R. Downregulation of TRPC4 and TRPC5 Inhibits Smooth Muscle Cell Proliferation without Affecting Endothelial Cell Proliferation. Genet Res (Camb) 2021;2021:2949986. [PMID: 34899056 DOI: 10.1155/2021/2949986] [Reference Citation Analysis]
9 Thompson B, Satin LS. Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion. Compr Physiol 2021;11:1-21. [PMID: 34636409 DOI: 10.1002/cphy.c210004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 de Sousa Valente J, Alawi KM, Bharde S, Zarban AA, Kodji X, Thapa D, Argunhan F, Barrett B, Nagy I, Brain SD. (-)-Englerin-A Has Analgesic and Anti-Inflammatory Effects Independent of TRPC4 and 5. Int J Mol Sci 2021;22:6380. [PMID: 34203675 DOI: 10.3390/ijms22126380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ningoo M, Plant LD, Greka A, Logothetis DE. PIP2 regulation of TRPC5 channel activation and desensitization. J Biol Chem 2021;296:100726. [PMID: 33933453 DOI: 10.1016/j.jbc.2021.100726] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
12 Sabnis RW. Novel Pyridazinones as TRPC5 Inhibitors for Treating Kidney Diseases. ACS Med Chem Lett 2021;12:526-7. [PMID: 33859787 DOI: 10.1021/acsmedchemlett.1c00123] [Reference Citation Analysis]
13 Song K, Wei M, Guo W, Quan L, Kang Y, Wu JX, Chen L. Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife 2021;10:e63429. [PMID: 33683200 DOI: 10.7554/eLife.63429] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
14 Ningoo M, Plant LD, Greka A, Logothetis DE. PIP2 regulation of TRPC5 channel activation and desensitization.. [DOI: 10.1101/2021.01.25.428089] [Reference Citation Analysis]
15 Wright DJ, Simmons KJ, Johnson RM, Beech DJ, Muench SP, Bon RS. Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site. Commun Biol 2020;3:704. [PMID: 33230284 DOI: 10.1038/s42003-020-01437-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
16 Liu B, Zhang W, Guo S, Zuo Z. Discovery of novel modulators targeting human TRPC5: Docking-based virtual screening, molecular dynamics simulation and binding affinity predication. J Mol Graph Model 2021;102:107795. [PMID: 33161371 DOI: 10.1016/j.jmgm.2020.107795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Marchetti C, Gavazzo P, Burlando B. Epigallocatechin-3-gallate mobilizes intracellular Ca2+ in prostate cancer cells through combined Ca2+ entry and Ca2+-induced Ca2+ release. Life Sci 2020;258:118232. [PMID: 32781066 DOI: 10.1016/j.lfs.2020.118232] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Yu Y, Liang Q, Du L, Jiang H, Gu J, Hu H, Tu Z. Synthesis and Characterization of a Specific Iodine-125-Labeled TRPC5 Radioligand. ChemMedChem 2020;15:1854-60. [PMID: 32717096 DOI: 10.1002/cmdc.202000339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Aroke EN, Powell-Roach KL, Jaime-Lara RB, Tesfaye M, Roy A, Jackson P, Joseph PV. Taste the Pain: The Role of TRP Channels in Pain and Taste Perception. Int J Mol Sci 2020;21:E5929. [PMID: 32824721 DOI: 10.3390/ijms21165929] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
20 Ahmadizadeh Shendy S, Babazadeh M, Shahverdizadeh GH, Hosseinzadeh-Khanmiri R, Es'haghi M. Synthesis of the quinazolinone derivatives using an acid-functionalized magnetic silica heterogeneous catalyst in terms of green chemistry. Mol Divers 2021;25:889-97. [PMID: 32078143 DOI: 10.1007/s11030-020-10033-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bauer CC, Minard A, Pickles IB, Simmons KJ, Chuntharpursat-bon E, Burnham MP, Kapur N, Beech DJ, Muench SP, Wright MH, Warriner SL, Bon RS. Xanthine-based photoaffinity probes allow assessment of ligand engagement by TRPC5 channels. RSC Chem Biol 2020;1:436-48. [DOI: 10.1039/d0cb00126k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
22 Pablo JL, Greka A. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases. Trends Pharmacol Sci 2019;40:911-8. [PMID: 31704171 DOI: 10.1016/j.tips.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 [DOI: 10.1101/2020.04.17.047456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 [DOI: 10.1101/2020.04.21.052910] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]